SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending after announcing positive Phase 2 S-OLARIS trial results for sonelokimab in axial spondyloarthritis, showcasing "disease modifying" potential and "best-in-class" efficacy. The community anticipates a significant re-valuation and potential short squeeze, fueled by strong financial positioning and upcoming Investor Day presentations.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending following its robust Q4 and full-year 2025 earnings report, which highlighted record revenue and strong production fueled by elevated silver prices. The community is highly bullish, emphasizing the company's unique advantage of owning its own mint, its strong correlation to the metal's rising value, and its potential for significant upside amidst ongoing discussions of silver scarcity and market dynamics.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

USO is trending due to escalating US-Iran tensions, fueled by a significant US military buildup in the Middle East and President Trump's warnings of potential military action. This has sparked intense community debate over a looming "war premium" for crude oil, with some anticipating a major price surge while others point to global oversupply and potential Venezuelan output as counteracting forces.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending following new positive preclinical and clinical data for its inflammatory bowel disease drug, obefazimod, presented at a major medical congress, which is intensifying rumors of a potential acquisition by major pharmaceutical companies. The community is actively discussing a looming bidding war, with many believing the stock is significantly undervalued despite company denials and official statements to the contrary.

Super Group (SGHC) Ltd. is a global digital gaming company, which engages in the global online sports betting and gaming businesses, Betway, a premier online sports betting brand, and Spin, a multi-brand online casino offering. It operates through the following segments: Betway, Spin, and Other. The Betway segment focuses on the ingle brand online sportsbook and online casino focused business with a global footprint and strategic partnerships. The Spin segment relates to the multi-brand online casino focused business with established market leadership in high-growth markets. The company was founded in July 2020 and is headquartered in St. Peter Port, the United Kingdom.

Super Group (SGHC) Limited

Super Group (SGHC) is trending amid discussions of a potential short squeeze, fueled by recent strong financial results that include Q3 earnings beats, raised guidance, and a special dividend. The community highlights its debt-free, profitable status and global focus, particularly in Africa and Europe, positioning it as an undervalued player in the iGaming sector despite broader market volatility.

Berachain

Berachain (BERA) is generating buzz with its unique Proof-of-Liquidity L1 blockchain, fueled by recent news of a substantial crypto treasury initiative and continuous technical advancements such as programmable wallets. The community is sharply divided, with bulls anticipating significant upside from its growing ecosystem, while bears point to recent price volatility and concerns over token supply.

Select Water Solutions, Inc. engages in the provision of water management and chemical solutions. It operates through the following business segments: Water Infrastructure, Water Services, and Chemical Technologies. The Water Infrastructure segment develops, builds, and operates permanent and semi-permanent infrastructure solutions to support full life cycle water management and waste treatment solutions. The Water Services segment consists of services businesses, including water transfer, flowback and well testing, fluids hauling, water containment and water network automation, primarily serving E&P companies. The Chemical Technologies segment includes logistics and provides a full suite of chemicals used in hydraulic fracturing, stimulation, cementing, pipelines and well completions. The company was founded on November 21, 2016 and is headquartered in Gainesville, TX.

Select Water Solutions Inc - Ordinary Shares - Class A

Select Energy Services Inc - Ordinary Shares - Class A

A recently priced public offering of Class A common shares at a 10% discount is sparking conversation around Select Water Solutions, as the community debates the near-term impact of dilution against the company's long-term growth plans for water infrastructure. Many investors are closely watching if robust fundamentals and strong projections for its sustainable water management business will quickly absorb the new shares.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is trending as it grapples with the recent departure of its COO, CFO, and CLO, alongside weak preliminary guidance and a strategic exit from international markets. This corporate overhaul fuels community concern and frustration regarding the company's stability and prior IPO performance, despite some bullish outlooks on its prediction market and crypto potential.

Nutanix, Inc. engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers' enterprise infrastructure. The company was founded by Dheeraj Pandey, Ajeet Singh, and Mohit Aron in 2009 and is headquartered in San Jose, CA.

Nutanix Inc - Ordinary Shares - Class A

Nutanix Inc 

Nutanix is trending after reporting strong Q3 financial results that exceeded expectations, delivering solid guidance, and announcing a $300 million accelerated share repurchase program. The community is buzzing about the company's expanding presence in hybrid cloud and AI infrastructure, capitalizing on strategic partnerships and perceived opportunities as enterprises reconsider Broadcom's VMware offerings.

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.

Foghorn Therapeutics Inc

Foghorn Therapeutics is trending after Eli Lilly selected its FHD-909 BRM selective inhibitor for clinical development, a significant validation of its chromatin biology platform. This news, coupled with multiple analyst upgrades, fuels community discussion around its undervaluation and potential for future milestones or acquisition in the targeted protein degradation sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Triodos Investment Management BV Raises Position in Zebra Technologies Corporation $ZBRA

Triodos Investment Management BV grew its position in shares of Zebra Technologies Corporation (NASDAQ:ZBRA - Free Report) by 79.2% during the third quarter, according to the company in its most...

Kovitz Investment Group Partners LLC Has $117.30 Million Stock Position in Zebra Technologies Corporation $ZBRA

Kovitz Investment Group Partners LLC lifted its holdings in Zebra Technologies Corporation (NASDAQ:ZBRA - Free Report) by 1.0% in the 3rd quarter, according to the company in its most recent 13F...

Here's Why Zebra Technologies (ZBRA) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zebra Technologies Corporation $ZBRA Shares Purchased by Vanguard Group Inc.

Vanguard Group Inc. grew its position in shares of Zebra Technologies Corporation (NASDAQ:ZBRA - Free Report) by 1.3% during the 3rd quarter, according to the company in its most recent filing with...

Zebra Technologies Corporation $ZBRA Stock Holdings Increased by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its holdings in shares of Zebra Technologies Corporation (NASDAQ:ZBRA - Free Report) by 1.0% in the 3rd quarter, according to the company in its most recent disclosure...

Can Zebra (ZBRA) Climb 38.01% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 38% in Zebra (ZBRA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zebra Technologies (ZBRA) is a Top-Ranked Growth Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

SG Capital Management LLC Trims Stake in Zebra Technologies Corporation $ZBRA

SG Capital Management LLC lessened its position in Zebra Technologies Corporation (NASDAQ:ZBRA - Free Report) by 48.6% in the third quarter, according to the company in its most recent filing with...

Zebra Technologies Corporation $ZBRA Shares Bought by Assetmark Inc.

Assetmark Inc. boosted its position in shares of Zebra Technologies Corporation (NASDAQ:ZBRA - Free Report) by 30.5% during the 3rd quarter, according to the company in its most recent disclosure...

Zebra Technologies Corporation $ZBRA Shares Acquired by Summitry LLC

Summitry LLC boosted its stake in shares of Zebra Technologies Corporation (NASDAQ:ZBRA - Free Report) by 5.2% during the 3rd quarter, according to the company in its most recent filing with the...

Zebra Technologies Corp. engages in the design, manufacture, and sale of automatic identification and data capture products. Its products include mobile computers, barcode scanners, radio frequency identification devices readers, specialty printers for barcode labeling and personal identification, real-time location systems, accessories and supplies, such as self-adhesive labels and other consumables, and software utilities and applications. It also provides services such as maintenance, technical support, repair, and managed and professional services, including cloud-based subscriptions. It operates through Asset Intelligence and Tracking and Enterprise Visibility and Mobility segments. The Asset Intelligence and Tracking segment is involved in barcode and card printing, location solutions, supplies, and services. The Enterprise Visibility and Mobility segment focuses on mobile computing, data capture, and RFID. The company was founded by Edward L. Kaplan and Gerhard Cless in 1969 and is headquartered in Lincolnshire, IL.

ZBRA
Zebra Technologies Corp. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ZBRA News

ZBRAZebra Technologies Corp. - Ordinary Shares - Class A